Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm
- Department of Ophthalmology, College of Medicine, University of Vermont, Burlington, Vermont, USA
- Correspondence to: David J Weissgold, MD, Ophthalmology, UVM/FAHC, 1 S Prospect Street, Burlington, VT 05401, USA; david.weissgold{at}vtmednet.org
- Accepted 9 April 2002
Central serous chorioretinopathy (CSR) is an uncommon cause of central visual loss, metamorphopsia, and dyschromatopsia, generally involving submacular and/or subretinal pigment epithelial (RPE) fluid blisters. While most cases of CSR are idiopathic, several associated risk factors have been implicated, such as so called type A personality, emotional stress, and male sex.1 Systemic steroid use has long been known to be associated with CSR.2 This case report demonstrates the development of CSR secondary to inhaled steroid use specifically for the management of post-mycoplasmal bronchospasm.
Case report
We evaluated a 40 year old white woman for complaints of metamorphopsia and decreased visual acuity on the left side for approximately a 2 month period. She denied previous similar episodes in either eye. Four months earlier, treatment for bronchospasm following mycoplasmal pneumonia had been initiated …
